Nira Bloom-Varda

Tel Litwinsky, TA, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Long-term hematopoietic dysfunction in patients with large-scale mitochondrial DNA deletion syndromes.

Long-term hematopoietic dysfunction in patients with large-scale mitochondrial DNA deletion syndromes.

Journal: Pediatric blood & cancer

Published: January 17, 2024

Mitochondrial augmentation of hematopoietic stem cells in children with single large-scale mitochondrial DNA deletion syndromes.

Mitochondrial augmentation of hematopoietic stem cells in children with single large-scale mitochondrial DNA deletion syndromes.

Journal: Science translational medicine

Published: December 21, 2022

αβ+ /CD19+ -depleted haploidentical stem cell transplantation for children with acute leukemia: Is there a protective effect of increased γδ+ T-cell content in the graft?

αβ+ /CD19+ -depleted haploidentical stem cell transplantation for children with acute leukemia: Is there a protective effect of increased γδ+ T-cell content in the graft?

Journal: Pediatric transplantation

Published: October 18, 2022

Point-of-care CAR T-cell therapy as salvage strategy for out-of-specification tisagenlecleucel.

Point-of-care CAR T-cell therapy as salvage strategy for out-of-specification tisagenlecleucel.

Journal: Leukemia & lymphoma

Published: September 16, 2022

Long-acting granulocyte colony-stimulating factor pegfilgrastim (lipegfilgrastim) for stem cell mobilization in multiple myeloma patients undergoing autologous stem cell transplantation.

Long-acting granulocyte colony-stimulating factor pegfilgrastim (lipegfilgrastim) for stem cell mobilization in multiple myeloma patients undergoing autologous stem cell transplantation.

Journal: International journal of hematology

Published: February 21, 2021

Haploidentical hematopoietic stem cell transplantation with αβTCR+/CD19+ depletion in pediatric patients with malignant and non-malignant disorders.

Haploidentical hematopoietic stem cell transplantation with αβTCR+/CD19+ depletion in pediatric patients with malignant and non-malignant disorders.

Journal: Bone marrow transplantation

Published: August 22, 2019

A simplified method for detection of N-terminal valine adducts in patients receiving treosulfan.

A simplified method for detection of N-terminal valine adducts in patients receiving treosulfan.

Journal: Rapid communications in mass spectrometry : RCM

Published: April 03, 2019

Peroxisome proliferator-activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target.

Peroxisome proliferator-activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target.

Journal: EMBO molecular medicine

Published: December 03, 2017

Dissecting the mechanisms involved in anti-human T-lymphocyte immunoglobulin (ATG)-induced tolerance in the setting of allogeneic stem cell transplantation - potential implications for graft versus host disease.

Dissecting the mechanisms involved in anti-human T-lymphocyte immunoglobulin (ATG)-induced tolerance in the setting of allogeneic stem cell transplantation - potential implications for graft versus host disease.

Journal: Oncotarget

Published: May 12, 2017

Comparison of two cytoreductive regimens for αβ-T-cell-depleted haploidentical HSCT in pediatric malignancies: Improved engraftment and outcome with TBI-based regimen.

Comparison of two cytoreductive regimens for αβ-T-cell-depleted haploidentical HSCT in pediatric malignancies: Improved engraftment and outcome with TBI-based regimen.

Journal: Pediatric blood & cancer

Published: May 08, 2017

Peroxisome proliferator-activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target

Peroxisome proliferator-activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target

Journal: EMBO molecular medicine

Published: March 10, 2017

Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia.

Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia.

Journal: Oncotarget

Published: September 30, 2016

Showing 1-12 of 16

Last Updated: 09/26/2026